XRCC6 and breast cancer: Despite applying the same doses, while BRCA1 and BRCA2 were up-regulated, the expression of ATM (p < 0.001), RAD51 (p < 0.001), and KU70 (p < 0.001) was downregulated in BC-SCs treated with the specified doses (p < 0.001).